In alignment with the White House Initiative on Women’s Health Research, the National Institutes of Health (NIH) is issuing a Notice of Special Interest (NOT-OD-24-079) to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause).

The NHLBI invites small business concerns developing new technologies that may improve the treatment, diagnosis, prevention, and research of heart, lung, blood, and sleep (HLBS) conditions in female patients to apply through this NOSI.